Urogen Pharma Ltd (URGN)

Finanzdaten der Urogen Pharma Ltd-Aktie (URGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	42.18%72.46	50.96	37.84	27.48	24.22
Cost Of Revenue	58.78%6.57	4.14	3.29	3.28	3.55
Gross Profit	40.72%65.88	46.82	34.55	24.20	20.67
	5.92%48.44	51.49	-	-	-
Selling, General, and Administrative	5.92%48.44	51.49	-	-	-
Research and Development	11.15%17.34	15.60	-	-	-
Operating Income/Loss	100.55%0.11	-20.26	-19.12	-27.39	-41.45
Nonoperating Income/Loss	7.43%-0.35	-0.32	-0.01	-0.20	-0.38
Income/Loss From Continuing Operations Before Tax	69.23%-8.72	-28.35	-26.64	-34.40	-48.93
Income Tax Expense/Benefit	217.96%5.63	-4.77	-0.28	-1.05	1.02
	39.12%-14.35	-23.57	-26.36	-33.35	-49.94
Attributable To Parent	39.12%-14.35	-23.57	-26.36	-33.35	-49.94
Basic Average Shares	0.39%50.38	50.18	0.37	48.06	47.74
Basic Earnings Per Share	40.43%-0.28	-0.47	-0.53	-0.69	-1.05